SCHEMBL5779828

SCHEMBL5779828

C[C@H](CC(=O)O)c1ccc2c(c1)CCN2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
MAPT P10636 2/20 0.47
GAA P10253 1/20 0.47
TSHR P16473 1/20 0.47
ATM Q13315 1/20 0.45
DRD2 P14416 1/20 0.45
DRD4 P21917 1/20 0.45
FFAR1 O14842 3/20 0.42
KDM4E B2RXH2 1/20 0.42
GFER P55789 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5779829 1.00 ALDH1A1 (0.47) ALDH1A1MAPTGAATSHRATM
SCHEMBL5778799 0.92 MAPT (0.54) ALDH1A1MAPTGAATSHRATM
SCHEMBL5778803 0.92 MAPT (0.54) ALDH1A1MAPTGAATSHRATM
SCHEMBL5782408 0.83 ALDH1A1 (0.48) ALDH1A1MAPTGAATSHRATM
SCHEMBL5782404 0.83 ALDH1A1 (0.48) ALDH1A1MAPTGAATSHRATM
SCHEMBL5783298 0.83 ALDH1A1 (0.56) ALDH1A1MAPTGAATSHRATM
SCHEMBL5783295 0.83 ALDH1A1 (0.56) ALDH1A1MAPTGAATSHRATM
Hydrochloric Acid SCHEMBL5780680 0.82 ALDH1A1 (0.47) ALDH1A1MAPTGAATSHRATM
Hydrochloric Acid SCHEMBL5780571 0.82 ALDH1A1 (0.47) ALDH1A1MAPTGAATSHRATM
Hydrochloric Acid SCHEMBL5780570 0.82 ALDH1A1 (0.47) ALDH1A1MAPTGAATSHRATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1114028-B1 AZA-BICYCLES WHICH MODULATE THE INHIBITION OF CELL ADHESION AVENTIS PHARMA LTD (GB) 2006-11-29 EP disclosed
US-6608084-B1 Treatment of human or non-human animal patient suffering from, or subject to, condition which can be ameliorated by administration of inhibitor of alpha 4 beta 1 mediated cell adhesion AVENTIS PHARMA LTD. (GB) 2003-08-19 US disclosed
EP-1114028-A1 AZA-BICYCLES WHICH MODULATE THE INHIBITION OF CELL ADHESION Aventis Pharma Limited (GB) 2001-07-11 EP disclosed
WO-2000015612-A1 AZA-BICYCLES WHICH MODULATE THE INHIBITION OF CELL ADHESION AVENTIS PHARMA LIMITED (GB) 2000-03-23 WO disclosed